IP Library › Assignment 024562/0561
Patent Assignment
Reel/Frame 024562/0561

Assignment of Assignor's Interest

Recorded: 2010-06-21 Pages: 6
Assignors
YEDGAR, SAUL
Executed: 2010-05-16
COHEN, YUVAL
Executed: 2010-05-25
Assignees
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
THE HEBREW UNIVERSITY OF JERSUALEM, P.O. BOX 39135, JERUSALEM, 91390, ISRAEL
MORRIA BIOPHARMACEUTICALS
53 DAVIES STREET, MAYFAIR, LONDON, W1K5JH, UNITED KINGDOM
Covered Property (1)
Use of Lipid Conjugates in the Treatment of Diseases or Disorders of the Eye
Patent: 8,865,681 →
Application: 11/984,223 →
Publication: US 2008/0113935
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Corrective Assignment to Correct the Applicant Name from Morria Biopharmaceuticals to Celsus Therapeutics Plc Previously Recorded on Reel 102456 Frame 0561. Assignor(S) Hereby Confirms the Applicant Morria Biopharmaceuticals. Aug 22, 2014
From: MORRIA BIOPHARMACEUTICALS
To: CELSUS THERAPEUTICS PLC
Reel/Frame 033663/0259 →
Assignment of Assignor's Interest Jun 6, 2018
From: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD
To: YEDGAR, SAUL
Reel/Frame 046006/0942 →